The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

Nevus Clinical Trial

Official title:
The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

Status Completed

Clinical Trial Summary

ApolloVue® S100 Image System is a medical device class II. The objective of this protocol is to image skin of healthy volunteers and to evaluate the performance of full-field optical coherence tomography (FF-OCT) device - the ApolloVue® S100 Image System in imaging skin microstructures of healthy skin at different anatomical locations and nevi for different skin types and different age and to evaluate usability of the ApolloVue® S100 Image System.

Clinical Trial Description

The OCT can provide cellular resolution (~1μm in lateral and axial directions) images. A cellular resolution OCT has the characteristics of non-invasive, non-radioactive, labelfree, real-time and high tissue penetration depth that are highly valuable for clinical use. This technology allows visualization of important structural features such as the epidermis and dermis and the epidermal-dermal junction. OCT has the advantage of generating cross-sectional images, like the orientation of pathology slides. The ApolloVue® S100 Image System is intended to be used as a non-invasive imaging tool in the evaluation of external human skin tissue microstructure by providing two-dimensional, crosssectional (B-scan) and en face (E-scan) real-time visualization for assessment by physicians to support in forming a clinical judgment. For the ApolloVue® S100 Image System image, both cross-sectional view and en face view can be obtained to assist physicians' diagnosis. With both views, physicians can obtain important spatial information in regards to the skin. Besides, the ApolloVue® S100 Image System is equipped with an image guiding system which provides a high-resolution dermatoscope like image, for the positioning of skin sites for optical biopsies. In this protocol, it is proposed to study the optical imaging features of healthy human skin and nevi and the evaluation of usability. We propose to recruit 60 subjects for such a trial. Healthy volunteers will be approached and consented to this protocol. The volunteers will be imaged. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04406454
Study type	Observational
Source	Taipei Veterans General Hospital, Taiwan
Contact
Status	Completed
Phase
Start date	July 6, 2020
Completion date	February 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01993654` - In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions	N/A
Completed	`NCT00487864` - In Vivo Confocal Scanning Laser Microscopy of Benign Nevi	N/A
Not yet recruiting	`NCT05418959` - Genetic Risk Stratification of Pediatric Skin Lesions	Phase 1
Completed	`NCT02012751` - Nevus Doctor Clinical Decision Support	N/A
Completed	`NCT06046144` - Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
Completed	`NCT00005781` - Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles	N/A
Completed	`NCT04550000` - Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits
Terminated	`NCT01324609` - Detection of Choroidal Nevus Cells in Vitrectomy Fluid
Active, not recruiting	`NCT04705168` - Study of the Nevisense Device to Assess Atypical Skin Lesions
Completed	`NCT02809001` - The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure	Phase 1/Phase 2
Completed	`NCT00287001` - Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following Laser Treatment	N/A
Recruiting	`NCT04368247` - Skin Fluorescent Imaging (SFI) System in Patients With Nevi
Recruiting	`NCT05402046` - Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms	N/A
Active, not recruiting	`NCT00656227` - A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision	Phase 2
Recruiting	`NCT04353050` - Atypical MOLes and Melanoma Early Detection Study (MoleMed)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.